Biotron BITRF Stock
0.06 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
Other OTC
Market Cap
52.78M USD
LOW - HIGH [24H]
0.06
-
0.06 USD
VOLUME [24H]
5K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Biotron Price Chart
Biotron BITRF Financial and Trading Overview
| Biotron stock price | 0.06 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.0005 - 0.05 USD |
| Volume | 500 USD |
| Avg. Volume | 3.65K USD |
| Market Cap | 18.44M USD |
| Beta (5Y Monthly) | -1.238314 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BITRF Valuation Measures
| Enterprise Value | 12.04M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.1692176 |
| Price/Book (mrq) | 2.9214284 |
| Enterprise Value/Revenue | 4.026 |
| Enterprise Value/EBITDA | -7.298 |
Trading Information
Biotron Stock Price History
| Beta (5Y Monthly) | -1.238314 |
| 52-Week Change | -60.74% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.05 USD |
| 52 Week Low | 0.0005 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.02 USD |
BITRF Share Statistics
| Avg. Volume (3 month) | 3.65K USD |
| Avg. Daily Volume (10-Days) | 15.05K USD |
| Shares Outstanding | 901.95M |
| Float | 778.47M |
| Short Ratio | N/A |
| % Held by Insiders | 14.13% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -54.71% |
| Operating Margin (ttm) | -55.50% |
| Gross Margin | 100.00% |
| EBITDA Margin | -55.16% |
Management Effectiveness
| Return on Assets (ttm) | -22.44% |
| Return on Equity (ttm) | -41.91% |
Income Statement
| Revenue (ttm) | 2.99M USD |
| Revenue Per Share (ttm) | 0.004 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1.56M USD |
| EBITDA | -1649273 USD |
| Net Income Avi to Common (ttm) | -1635809 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.47M USD |
| Total Cash Per Share (mrq) | 0.007 USD |
| Total Debt (mrq) | 63.63K USD |
| Total Debt/Equity (mrq) | 1.08 USD |
| Current Ratio (mrq) | 8.528 |
| Book Value Per Share (mrq) | 0.007 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1419348 USD |
| Levered Free Cash Flow (ttm) | -786606 USD |
Profile of Biotron
| Country | United States |
| State | NSW |
| City | Sydney |
| Address | 66 Hunter Street |
| ZIP | 2000 |
| Phone | 61 2 9300 3344 |
| Website | https://www.biotron.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
Q&A For Biotron Stock
What is a current BITRF stock price?
Biotron BITRF stock price today per share is 0.06 USD.
How to purchase Biotron stock?
You can buy BITRF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biotron?
The stock symbol or ticker of Biotron is BITRF.
Which industry does the Biotron company belong to?
The Biotron industry is Biotechnology.
How many shares does Biotron have in circulation?
The max supply of Biotron shares is 902.28M.
What is Biotron Price to Earnings Ratio (PE Ratio)?
Biotron PE Ratio is now.
What was Biotron earnings per share over the trailing 12 months (TTM)?
Biotron EPS is 0 USD over the trailing 12 months.
Which sector does the Biotron company belong to?
The Biotron sector is Healthcare.